Chugai Pharmaceutical Roche Reports Q1 Sales Performance; Chugai Pharmaceutical Included

TOKYO, Apr 23 (Pulse News Wire) – Chugai Pharmaceutical CO.,LTD. (4519.T), a subsidiary of Roche, is included in the reported figures.

As of December 31, 2025, Roche Holding AG owned 59.89% of Chugai's outstanding shares, representing 61.12% of voting rights. The detailed results are available on Roche Group’s website.

Chugai’s operating profit for the period from January 1 to March 31, 2026, contributed to the overall group performance. Chugai Pharmaceutical, headquartered in Tokyo, continues to play a significant role within the Roche Group, reflecting its strategic importance in the global pharmaceutical landscape.